1. Left Ventricular Midwall Fibrosis as a Predictor of Mortality and Morbidity After Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy
- Author
-
Kiran Patel, Tarek Haddad, Russell E A Smith, Robin J. Taylor, Paul W X Foley, Fraz Umar, Berthold Stegemann, Lawrence J. Mulligan, Sanjay K Prasad, and Francisco Leyva
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Heart Ventricles ,medicine.medical_treatment ,Cardiac resynchronization therapy ,Magnetic Resonance Imaging, Cine ,cardiac resynchronization therapy ,heart failure ,Sudden cardiac death ,Ventricular Dysfunction, Left ,midwall fibrosis ,Fibrosis ,Internal medicine ,nonischemic cardiomyopathy ,medicine ,Humans ,cardiovascular diseases ,Aged ,Retrospective Studies ,Ischemic cardiomyopathy ,Ejection fraction ,business.industry ,Hazard ratio ,Dilated cardiomyopathy ,Middle Aged ,Prognosis ,medicine.disease ,mortality ,United Kingdom ,Survival Rate ,Heart failure ,cardiovascular system ,Cardiology ,Female ,Morbidity ,Cardiomyopathies ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
ObjectivesThe aim of this study was to determine whether left ventricular (LV) midwall fibrosis, detected by midwall hyperenhancement (MWHE) on late gadolinium enhancement cardiovascular magnetic resonance (CMR) imaging, predicts mortality and morbidity in patients with dilated cardiomyopathy (DCM) undergoing cardiac resynchronization therapy (CRT).BackgroundMidwall fibrosis predicts mortality and morbidity in patients with DCM.MethodsPatients with DCM with (+) or without (−) MWHE (n = 20 and n = 77, respectively) as well as 161 patients with ischemic cardiomyopathy (ICM) undergoing CRT (n = 258) were followed up for a maximum of 8.7 years.ResultsAmong patients with DCM, +MWHE predicted cardiovascular mortality (hazard ratio [HR]: 18.6; 95% confidence intervals [CI]: 3.51 to 98.5; p = 0.0008), total mortality or hospitalization for major adverse cardiovascular events (HR: 7.57; 95% CI: 2.71 to 21.2; p < 0.0001), and cardiovascular mortality or heart failure hospitalizations (HR: 9.56; 95% CI: 2.72 to 33.6; p = 0.0004), independent of New York Heart Association class, QRS duration, atrial fibrillation, LV volumes, LV ejection fraction, and a CMR-derived measure of dyssynchrony. Among patients with DCM and ICM, the risk of cardiovascular mortality for DCM +MWHE (adjusted HR: 18.5; 95% CI: 3.93 to 87.3; p = 0.0002) was similar to that for ICM (adjusted HR: 21.0; 95% CI: 5.06 to 87.2; p < 0.0001). Both DCM +MWHE and ICM were predictors of pump failure death as well as sudden cardiac death. LV reverse remodeling was observed in DCM −MWHE and in ICM but not in DCM +MWHE.ConclusionsMidwall fibrosis is an independent predictor of mortality and morbidity in patients with DCM undergoing CRT. The outcome of DCM with midwall fibrosis is similar to that of ICM. This relationship is mediated by both pump failure and sudden cardiac death.
- Published
- 2012
- Full Text
- View/download PDF